Commentary by Josh Olstein MD, Associate Editor, Clinical Correlations
As a future gastroenterologist, I was drawn to a study in the October 4th edition of the New England Journal of Medicine that compared CT …
Commentary by Josh Olstein MD, Associate Editor, Clinical Correlations
As a future gastroenterologist, I was drawn to a study in the October 4th edition of the New England Journal of Medicine that compared CT …
Commentary by Daniel Frenkel, PGY-2
Case: A 46 year old male with diabetes on oral hypoglycemic medications is admitted to the hospital with one day of constant epigastric pain, nausea, vomiting, and an inability to tolerate oral intake. You are …
Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
Diabetic neuropathy is one of the most commonly encountered complications of diabetes mellitus. It is seen in up to …
Commentary by Danise Schiliro-Chuang MD, NYU Chief Resident
Let’s start on the theme of cardiovascular disease risk reduction, a topic making headlines this week. A September 28 New York Times article previews the release …
Commentary by Sumathi Sivapalasingam MD, NYU Division of Infectious Diseases
Rifaximin is an oral semi-synthetic analog of rifampin which is essentially not absorbed (bioavailability <0.4%) making it useful for the treatment of intra-luminal …
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to Case 3 of our special diabetes series intended to highlight the essentials …
Commentary by Sandeep Mangalmurti MD, JD PGY-2
“Pay-for performance” is the broadly encompassing term used to describe recent efforts to restructure physician compensation so that rewards are commensurate to performance. Initially limited to small …
Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
The sensation of déjà vu was likely very common this week. First, we experienced a flashback to 1994 when we saw OJ in handcuffs …